COMMUNIQUÉS West-GlobeNewswire

Avalyn Announces Additional Long-term Data on AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis to be Presented at the European Alliance of Associations for Rheumatology 2026
21/05/2026
BOSTON, May 21, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]
MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
21/05/2026
MARIETTA, Ga., May 21, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the Craig-Hallum 23 rd Annual [...]
NSK Dental Achieves Back-to-Back Top Ratings in Dental Product Shopper Peer Evaluations
21/05/2026
Ti-Max Z990L Earns 4.9 in 2024 and Ti-Max Z99L Earns a Perfect 5.0 in 2025 — Both the Highest-Ever Ratings in Their Respective Categories Hoffman Estates, IL, May 21, 2026 (GLOBE NEWSWIRE) -- NSK Dental (NSK/Nakanishi [...]
HNL Lab Medicine Receives 2026 Boomi Innovation Award for Advancing Integration and Automation in Healthcare
21/05/2026
ALLENTOWN, Pa., May 21, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine has been named a recipient of the 2026 Boomi Innovation Award, a national recognition honoring organizations that are using data, integration, and [...]
Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury
21/05/2026
U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury [...]
Iovance Biotherapeutics to Present at Upcoming Conference
21/05/2026
SAN CARLOS, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte [...]
Micron Biomedical Celebrates the Grand Opening of Its Commercial-Scale Manufacturing Site in Georgia
21/05/2026
National and local leaders across government, investors, life science industry and academia acknowledge the impact of Micron’s dissolvable vaccines and therapies on human health and economic development ALPHARETTA, Ga [...]
Akari Therapeutics Announces $5.5 Million Private Placement Offering
21/05/2026
TAMPA, Fla. and LONDON, May 21, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with a novel RNA splicing modulator payload, [...]
Realize Medical Appoints Entrepreneur and Investor Tom Kaneb to Board of Directors
21/05/2026
OTTAWA, Ontario, May 21, 2026 (GLOBE NEWSWIRE) -- Realize Medical , a global leader in immersive medical imaging and virtual reality solutions for surgical planning and medical collaboration, today announced the [...]
NewGenIVF Announces Strategic Investment Agreement with Tech Veteran Andy Cheung-Led K25.ai, an AI-Powered Live-Streaming Prediction Market, at US$100 Million Valuation
21/05/2026
Initial US$2 million strategic investment values K25.ai at US$100 million pre-money, with option to invest up to US$10 million if exercised in full; exclusive APAC agency partnership provides NewGenIVF with exposure to [...]
Genvor Appoints Donald Kalkofen as Chief Financial Officer
21/05/2026
Seasoned biotech CFO brings 20+ years of public company finance leadership and IPO experience to support Genvor’s dual-market growth strategy Woodland, CA, May 21, 2026 (GLOBE NEWSWIRE) -- Genvor, Inc. (OTCQB: GNVR) (“ [...]
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
21/05/2026
NORWOOD, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on developing promising new therapies in oncology and obesity, today announced that [...]
‘Pour La Passe’: Haleon Canada lance une campagne nationale avec Canada Soccer pour célébrer les petits gestes de santé derrière le bien-être des Canadiens
21/05/2026
Une nouvelle campagne publicitaire de Haleon Canada, mettant en vedette Richie Laryea, donne vie une campagne intégrée qui englobe les médias, le commerce de détail et une tournée expérientielle à travers le pays [...]
Nanobiotix Announces Trading Resumption of Its Ordinary Shares on Euronext Paris
21/05/2026
PARIS and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based [...]
Brain Cancer Canada Awards The Dwayne Andrews Glioblastoma Research Grant to Tackle One of the Most Aggressive Brain Tumours and Unlock Immunotherapy Breakthroughs for Young Patients
21/05/2026
TORONTO, May 21, 2026 (GLOBE NEWSWIRE) -- Brain Cancer Canada (BCC), the country’s only 100% volunteer-driven charity dedicated exclusively to funding brain cancer research nationwide, is proud to award $50,000 through [...]
Nanobiotix Announces Pricing of Oversubscribed €85m Global Offering
21/05/2026
PARIS, France and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based [...]
CytomX Therapeutics to Present at Upcoming June Investor Conferences
21/05/2026
SOUTH SAN FRANCISCO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that management will [...]
Biodesix to Participate in Upcoming Investor Conferences
21/05/2026
LOUISVILLE, Colo., May 21, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that members of the Biodesix leadership team will participate in three upcoming [...]
Immix Biopharma Announces 95% Complete Response Rate in Interim Update From relapsed/refractory AL Amyloidosis Clinical Trial NEXICART-2
21/05/2026
– Of first 20 patients, all four MRD-negative patients have converted to complete response (CR) – – CR rate now 95% (19 of 20 patients) – – All CRs reached within 1 year of follow-up post-dosing – – No relapses to-date [...]

Pages